Bacillus calmette-guerin substrain connaught live antigen

Bacillus calmette-guerin substrain connaught live antigen Uses, Dosage, Side Effects, Food Interaction and all others data.

Bacillus calmette-guerin substrain connaught live antigen is intravesically administered for the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder and for the prophylaxis of primary or recurrent stage Ta and/or T1 papillary tumors following transurethral resection (TUR). The solution contains live, attenuated strain of Mycobacterium bovis. It is prepared from the Connaught strain of Bacillus Calmette and Guérin.

Table Of contents

• Bacillus calmette-guerin substrain connaught live antigen
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Bacillus calmette-guerin substrain connaught live antigen
Generic	Bacillus calmette-guerin substrain connaught live antigen
Bacillus calmette-guerin substrain connaught live antigen Other Names	BCG, Live, Connaught Strain
Type
Groups	Approved, Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Indicated for intravesical use in the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder and for the prophylaxis of primary or recurrent stage Ta and/or T1 papillary tumors following transurethral resection (TUR).

Bacillus calmette-guerin substrain connaught live antigen is also used to associated treatment for these conditions: Carcinoma in situ of urinary bladder, Primary stage T1 papillary tumors, Primary stage Ta papillary tumors, Recurrent stage T1 papillary tumors, Recurrent stage Ta papillary tumors, Salvage therapy

Innovators Monograph

You find simplified version here Bacillus calmette-guerin substrain connaught live antigen